🇺🇸 FDA
Patent

US 7784616

Dispenser for progestin used for acute maintenance treatment of DUB

granted A61KA61K31/519A61K31/57

Quick answer

US patent 7784616 (Dispenser for progestin used for acute maintenance treatment of DUB) held by TEVA WOMEN'S HEALTH, INC. expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA WOMEN'S HEALTH, INC.
Grant date
Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/519, A61K31/57, A61K33/06, A61K33/26